Real World Evidence has moved from the periphery of HealthTech to the centre of it. Regulators are accepting RWE in support of label expansions and…
Real World Evidence has moved from the periphery of HealthTech to the centre of it. Regulators are accepting RWE in support of label expansions and…
The commercial success of GLP-1 receptor agonists has done something unusual for a pharmaceutical category: it has generated an entirely new HealthTech sector almost overnight. …
The Chief Product Officer role in HealthTech has always been more complex than its equivalent in consumer software. Clinical validation, regulatory pathway, patient safety obligations…